| OrganiGram (OGI) Reports Q2 Loss, Beats Revenue Estimates (Revised) |
OrganiGram (OGI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago. |
zacks.com |
2025-05-13 00:15:33 |
Czytaj oryginał (ang.) |
| Organigram Lights Up Q2 With 74% Sales Surge, Profitable Turn |
Cannabis grower Organigram Holdings Inc OGI reported second-quarter 2025 net sales of $45.7 million (approximately CA$65.6 million). That's up 74% year-over-year, beating the consensus of $42.28 million. |
benzinga.com |
2025-05-12 14:40:53 |
Czytaj oryginał (ang.) |
| Organigram Global Inc. (OGI) Q2 2025 Earnings Call Transcript |
Organigram Global Inc. (NASDAQ:OGI ) Q2 2025 Earnings Conference Call May 12, 2025 8:00 AM ET Company Participants Max Schwartz - Investor Relations Beena Goldenberg - Chief Executive Officer Greg Guyatt - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Yewon Kang - Canaccord Genuity Operator Good morning. My name is Krista, and I will be your conference operator today. |
seekingalpha.com |
2025-05-12 14:16:35 |
Czytaj oryginał (ang.) |
| OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates |
OrganiGram (OGI) came out with a quarterly loss of $0.13 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.12 per share a year ago. |
zacks.com |
2025-05-12 12:45:36 |
Czytaj oryginał (ang.) |
| Organigram Reports Record Second Quarter Fiscal 2025 Results |
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced its record results for the second quarter ended March 31, 2025 (“Q2 Fiscal 2025”). The Q2 Fiscal 2025 results include a full quarter of consolidated financials from the Company's acquisition of Motif Labs Ltd. ("Motif") on December 6, 2024. Q2 FISCAL 2025 HIGHLIGHTS Gross revenue increased 79% to $102.8 million from $57.4 million in. |
businesswire.com |
2025-05-12 10:00:00 |
Czytaj oryginał (ang.) |
| Organigram Global's Collective Project Wins Big at the 2025 High Spirits Awards in California |
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce that its recently acquired business, Collective Project, has won recognition at the 2025 High Spirits Awards only a few short months following the launch of the brand in the U.S. The brand received a gold award for Blood Orange, Yuzu & Vanilla and a platinum award for Mango, Pineapple & Coconut hemp-derived THC b. |
businesswire.com |
2025-05-07 10:00:00 |
Czytaj oryginał (ang.) |
| Organigram Global Wins “Exporter of the Year” at the 2025 New Brunswick Export Awards |
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (“the Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce it has been named Exporter of the Year by Opportunities New Brunswick (“ONB”) as part of the 2025 New Brunswick Export Awards, ONB's flagship annual event recognizing the successes and innovative approaches of New Brunswick's many exporting companies. This honour recognizes Organigram's significant growth in internationa. |
businesswire.com |
2025-05-05 10:00:00 |
Czytaj oryginał (ang.) |
| Organigram to Report Second Quarter Fiscal 2025 Results on May 12, 2025 |
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, announced today it will report earnings results for its second quarter fiscal 2025 ended March 31, 2025, on Monday, May 12, 2025, prior to market open. The Company will host a conference call to discuss its results with details as follows: Date: Monday, May 12, 2025 Time: 8:00 am Eastern Time To register for the conference call, please use thi. |
businesswire.com |
2025-05-02 10:00:00 |
Czytaj oryginał (ang.) |
| Organigram Global's Products Recognized at the CNB Awards |
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce that three of its consumer brands — SHRED, Edison, and Trailblazer — earned honours at the recent CNB Leadership Conference and the Cannabis NB Cup. Inspired by the legacy events that have shaped cannabis culture over the years, the Cannabis NB Cup celebrates the best in grow — with winners chosen by those who matter mos. |
businesswire.com |
2025-04-24 10:00:00 |
Czytaj oryginał (ang.) |
| Organigram Global Shares Recording of its OG Investor Session |
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram Global”), Canada's #1 cannabis company by market share, is pleased to share the full recording of its recently held OG Investor Session, now available online for shareholders, analysts, and industry stakeholders. To access a recording of the event please click here or visit www.organigram.ca/investors. “This session was a way for Organigram to engage directly with investors and industry stak. |
businesswire.com |
2025-04-22 10:00:00 |
Czytaj oryginał (ang.) |
| New Abacus Data Poll Reveals that Most Canadians See Cannabis as a Key Pillar of Canada's Economic Future |
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, today released new public opinion data showing strong national support for growing Canada's economy through homegrown industries, including the legal cannabis sector. The national survey, commissioned by Organigram Global and conducted by Abacus Data between April 3–8, 20251, arrives at a pivotal moment for Canada's economic and political futu. |
businesswire.com |
2025-04-16 10:00:00 |
Czytaj oryginał (ang.) |
| Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ |
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram Global”), the cannabis leader in Canada by market share, is pleased to announce its inaugural virtual investor event, the OG Investor Session, taking place on April 10, 2025, at 4pm EST. This online event offers investors a front-row seat to Organigram Global's next chapter. Attendees will gain valuable insights into the Company's growth trajectory, engage directly with leadership on key ind. |
businesswire.com |
2025-04-02 10:00:00 |
Czytaj oryginał (ang.) |
| Organigram Enters U.S. Through Acquisition of Collective Project Beverages |
TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), Canada's #1 cannabis company by market share, is pleased to announce the acquisition of 100% of the issued and outstanding shares of Collective Project Limited (“CPL”) for upfront consideration of approximately C$6.2 million, potential milestone payments and potential earnout payments totaling in the aggregate up to C$24M for the twelve-month periods ending September 30, 2025 and Septembe. |
businesswire.com |
2025-04-01 11:47:00 |
Czytaj oryginał (ang.) |
| Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence |
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is proud to announce its official rebrand to Organigram Global Inc. (“Organigram Global”), a move that demonstrates the Company's evolution from an East Coast medical cannabis company into a burgeoning global cannabis leader. Having achieved the number one position in market share in Canada1 and established a growing international footprint, Orga. |
businesswire.com |
2025-03-26 08:00:00 |
Czytaj oryginał (ang.) |
| Organigram Announces Results of Annual and Special Meeting, including Shareholder Approval of Name Change to Organigram Global Inc. |
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “Shareholders”) held virtually on March 24, 2025 (the “Meeting”). Shareholder Approval of the Name Change and Articles of Amendment At the Meeting, a special resolution approving an amendment to the articles of the Company to change the name of the Company to “Organigram Global Inc.” (the. |
businesswire.com |
2025-03-24 22:30:00 |
Czytaj oryginał (ang.) |
| Organigram Closes Third Tranche of Previously Announced BAT Private Placement Investment |
TORONTO--(BUSINESS WIRE)--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that on February 28, 2025, the Company closed the third and last of three tranches (the “Third Tranche”) of the previously announced C$124,559,674 follow-on strategic equity investment (the “Investment”) by BT DE Investments Inc. (the “Investor”), a wholly owned subsidiary of British American Tobacco plc (“BAT”). Pursuant to the T. |
businesswire.com |
2025-03-03 08:00:00 |
Czytaj oryginał (ang.) |
| Organigram Reports In-Line Q1 Results As Cannabis Sector Tanks |
Organigram reported improved financial results for Q1-2025. OGI expects revenue to increase for Q2 as well as cash positions. OGI:CA sees growth in its international cannabis sales and Canadian sales. |
seekingalpha.com |
2025-02-23 23:38:16 |
Czytaj oryginał (ang.) |
| Organigram Is A Small-Cap Bargain |
Organigram's stock has declined significantly, but my bullish outlook remains due to strong fundamentals, strategic investments, and potential acquisition by British American Tobacco. The company reported a 17% revenue growth in Q1 FY24, driven by international expansion and the Motif Labs acquisition, despite missing expectations. Organigram's balance sheet is robust with C$46.8 million in cash, no debt, and a healthy current ratio of 3.3X, mitigating many risks. |
seekingalpha.com |
2025-02-23 09:52:43 |
Czytaj oryginał (ang.) |
| Cannabis Producer Organigram Q1 Sales Jump 17%, Expect C$10 Million From Motif Integration, Annual Run-Rate Synergies Within Two Years |
On Tuesday, Cannabis producer Organigram Holdings Inc OGI reported first-quarter 2025 gross sales of CA$66.8 million, up 19% year-over-year, beating the consensus of CA$65.4 million. |
benzinga.com |
2025-02-11 12:13:25 |
Czytaj oryginał (ang.) |
| Organigram Holdings Inc. (OGI) Q1 2025 Earnings Call Transcript |
Organigram Holdings Inc. (NASDAQ:OGI ) Q1 2025 Earnings Conference Call February 11, 2025 8:00 AM ET Company Participants Max Schwartz - Director of IR Beena Goldenberg - CEO Greg Guyatt - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Yewon Kang - Canaccord Genuity Operator Good morning. My name is Krista, and I will be your conference operator today. |
seekingalpha.com |
2025-02-11 11:45:40 |
Czytaj oryginał (ang.) |